Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study

Cecere SC;Musacchio L;Bartoletti M;Salutari V;Arenare L;Lorusso D;Ronzino G;Lauria R;Cormio G;Naglieri E;Scollo P;Marchetti C;Raspagliesi F;Greggi S;Cinieri S;Bergamini A;Orditura M;Valabrega G;Scambia G;Martinelli F;De Matteis E;Cardalesi C;Loizzi V;Perniola G;Carella C;Scandurra G;Giannone G;Pignata S

2021-01-01